Medipharm Labs Interview with Proactive Investors
Perth, Sep 20, 2018 AEST (ABN Newswire) - MMJ PhytoTech Limited (
ASX:MMJ) (MMJJF:OTCMKTS) ("MMJ") is pleased to note the interview with Proactive Investors Vancouver given by Pat McCutcheon, President and CEO of MediPharm Labs, Inc. ("MediPharm Labs"), providing a detailed description of their business and revenue model.
The interview can be viewed at: http://www.abnnewswire.net/lnk/ZLIFSM6L
MMJ owns 6.9% of MediPharm Labs.
About MMJ Group Holdings Ltd
MMJ Group Holdings Ltd (ASX:MMJ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ's latest investor presentation and news, please visit: https://www.mmjphytotech.com.au/investors/
| ||
|
